0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Articles |

Outcome of Renal Crisis in Systemic Sclerosis: Relation to Availability of Angiotensin Converting Enzyme (ACE) Inhibitors

Virginia D. Steen, MD; Joseph P. Costantino, DrPH; Alvin P. Shapiro, MD; and Thomas A. Medsger Jr., MD
[+] Article and Author Information

Grant Support: In part by The Arthritis Foundation, Western Pennsylvania Chapter (Shoemaker Fund); and by the RGK Foundation.

Requests for Reprints: Virginia D. Steen, MD, 985 Scaife Hall, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261.

Current Author Addresses: Drs. Steen and Medsger: 985 Scaife Hall, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261. Dr. Costantino: Department of Biostatistics, University of Pittsburgh School of Public Health, Pittsburgh, PA 15261.

Dr. Shapiro: Shadyside Hospital, Centre Avenue, Pittsburgh, PA 15261.


©1990 American College of PhysiciansAmerican College of Physicians


Ann Intern Med. 1990;113(5):352-357. doi:10.7326/0003-4819-113-5-352
Text Size: A A A

Objective: To determine the outcome of scleroderma renal crisis before and after the availability of angiotensin converting enzyme (ACE) inhibitors.

Design: Evaluation of a large cohort of patients with systemic sclerosis and renal crisis who were followed prospectively.

Setting: University scleroderma center.

Patients: One hundred and eight patients who had scleroderma renal crisis between 1972 and 1987.

Intervention: ACE inhibitors.

Measurements and Main Results: Therapy with ACE inhibitors has dramatically improved the survival of patients with scleroderma 0renal crisis (1-year survival, 15% without and 76% with ACE inhibitors; P < 0.001). However, 24 (44%) of 55 patients with scleroderma renal crisis who were treated with ACE inhibitors died early or required permanent dialysis. Older age, male sex, an initial serum creatinine level of more than 270 µmol/L, inadequately controlled blood pressure, and congestive heart failure were associated with these poor outcomes, but only older age and congestive heart failure were significant in a multivariate logistic regression analysis. Eleven of twenty patients (55%) who survived dialysis more than 3 months and continued to receive therapy with ACE inhibitors were able to discontinue dialysis after 3 to 15 months compared with 0 of 15 dialysis patients who did not receive ACE-inhibitor therapy (P = 0.002).

Conclusions: Patients with systemic sclerosis who develop hypertension should be treated with an ACE inhibitor. Improved survival and successful discontinuation of dialysis are possible when ACE inhibitors are used to treat scleroderma renal crisis.

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)